US Stock MarketDetailed Quotes

IBO Impact BioMedical

Watchlist
  • 1.490
  • +0.240+19.20%
Close Oct 15 16:00 ET
17.13MMarket Cap-4037P/E (TTM)

Impact BioMedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0.00%50K
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
0.00%50K
--0
--0
Cost of revenue
Gross profit
Operating expense
-37.90%626K
-3.99%771K
16.62%4.03M
10.37%1.14M
21.26%1.08M
26.00%1.01M
13.26%803K
0.00%3.45M
-23.16%1.03M
14.23%889K
Selling and administrative expenses
-26.86%335K
28.78%434K
50.62%1.58M
34.31%274K
96.34%536K
59.58%458K
35.34%337K
0.00%1.05M
-54.67%204K
-3.13%273K
-Selling and marketing expense
80.00%18K
-52.94%8K
----
----
----
--10K
--17K
----
----
----
-General and administrative expense
-29.24%317K
33.13%426K
50.62%1.58M
34.31%274K
96.34%536K
56.10%448K
28.51%320K
0.00%1.05M
-54.67%204K
-3.13%273K
Research and development costs
--0
-72.07%50K
-6.44%1.15M
-11.30%463K
-27.58%239K
29.13%266K
6.55%179K
0.00%1.23M
-10.15%522K
73.96%330K
Depreciation amortization depletion
-0.36%279K
0.00%280K
0.63%1.12M
0.72%280K
0.36%280K
0.72%280K
0.72%280K
0.00%1.11M
0.00%278K
0.17%279K
-Depreciation and amortization
-0.36%279K
0.00%280K
0.63%1.12M
0.72%280K
0.36%280K
0.72%280K
0.72%280K
0.00%1.11M
0.00%278K
0.17%279K
Other operating expenses
200.00%12K
0.00%7K
170.59%184K
335.71%122K
228.57%23K
-86.21%4K
-50.00%7K
0.00%68K
-17.65%28K
-75.16%7K
Operating profit
37.90%-626K
3.99%-771K
-18.33%-4.03M
-10.37%-1.14M
-21.26%-1.08M
-34.40%-1.01M
-13.26%-803K
0.00%-3.4M
20.19%-1.03M
-14.23%-889K
Net non-operating interest income expense
-128.32%-258K
-131.63%-227K
1.60%-431K
31.84%-122K
-11.24%-99K
-130.61%-113K
-164.86%-98K
0.00%-438K
47.81%-179K
25.79%-89K
Non-operating interest income
0.00%3K
0.00%3K
-45.83%13K
103.75%3K
0.00%3K
-96.67%3K
-96.88%3K
0.00%24K
-35.59%-80K
-94.66%3K
Non-operating interest expense
125.00%261K
127.72%230K
-3.90%444K
26.26%125K
10.87%102K
-16.55%116K
-24.06%101K
0.00%462K
-65.14%99K
-47.75%92K
Other net income (expense)
101.29%52K
0
52K
0.00%-4.03M
Special income (charges)
----
----
--0
----
----
----
----
0.00%-4.1M
----
----
-Write off
----
----
--0
----
----
----
----
0.00%4.1M
----
----
Other non- operating income (expenses)
----
----
-21.21%52K
--0
----
----
--52K
0.00%66K
----
----
Income before tax
21.14%-884K
-17.55%-998K
44.05%-4.41M
75.96%-1.26M
-20.35%-1.18M
-40.30%-1.12M
-13.81%-849K
0.00%-7.88M
8.70%-5.25M
-6.25%-978K
Income tax
0
0
0
0
0
0
0
0.00%-621K
-378.12%-1.88M
1,258,100.00%1.26M
Net income
21.14%-884K
-17.55%-998K
39.26%-4.41M
62.54%-1.26M
47.36%-1.18M
-40.30%-1.12M
-13.81%-849K
0.00%-7.26M
37.11%-3.37M
-142.95%-2.24M
Net income continuous Operations
21.14%-884K
-17.55%-998K
39.26%-4.41M
62.54%-1.26M
47.36%-1.18M
-40.30%-1.12M
-13.81%-849K
0.00%-7.26M
37.11%-3.37M
-142.95%-2.24M
Minority interest income
126.32%5K
81.25%-36K
65.20%-71K
-550.00%-26K
77.61%-15K
71.64%-19K
-149.35%-192K
0.00%-204K
-105.13%-4K
41.72%-67K
Net income attributable to the parent company
19.33%-889K
-46.42%-962K
38.51%-4.34M
63.27%-1.24M
46.43%-1.16M
-50.55%-1.1M
1.79%-657K
0.00%-7.05M
38.08%-3.36M
-169.30%-2.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
19.33%-889K
-46.42%-962K
38.51%-4.34M
63.27%-1.24M
46.43%-1.16M
-50.55%-1.1M
1.79%-657K
0.00%-7.05M
38.08%-3.36M
-169.30%-2.17M
Basic earnings per share
19.33%-0.0773
-46.42%-0.0837
38.51%-0.3771
63.27%-0.1074
46.43%-0.1011
-50.55%-0.0958
1.81%-0.0571
0.00%-0.6133
38.08%-0.2924
-169.30%-0.1886
Diluted earnings per share
19.33%-0.0773
-46.42%-0.0837
38.51%-0.3771
63.27%-0.1074
46.43%-0.1011
-50.55%-0.0958
1.81%-0.0571
0.00%-0.6133
38.08%-0.2924
-169.30%-0.1886
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 00000000.00%50K00
Operating revenue --0--0--0--0--0--0--00.00%50K--0--0
Cost of revenue
Gross profit
Operating expense -37.90%626K-3.99%771K16.62%4.03M10.37%1.14M21.26%1.08M26.00%1.01M13.26%803K0.00%3.45M-23.16%1.03M14.23%889K
Selling and administrative expenses -26.86%335K28.78%434K50.62%1.58M34.31%274K96.34%536K59.58%458K35.34%337K0.00%1.05M-54.67%204K-3.13%273K
-Selling and marketing expense 80.00%18K-52.94%8K--------------10K--17K------------
-General and administrative expense -29.24%317K33.13%426K50.62%1.58M34.31%274K96.34%536K56.10%448K28.51%320K0.00%1.05M-54.67%204K-3.13%273K
Research and development costs --0-72.07%50K-6.44%1.15M-11.30%463K-27.58%239K29.13%266K6.55%179K0.00%1.23M-10.15%522K73.96%330K
Depreciation amortization depletion -0.36%279K0.00%280K0.63%1.12M0.72%280K0.36%280K0.72%280K0.72%280K0.00%1.11M0.00%278K0.17%279K
-Depreciation and amortization -0.36%279K0.00%280K0.63%1.12M0.72%280K0.36%280K0.72%280K0.72%280K0.00%1.11M0.00%278K0.17%279K
Other operating expenses 200.00%12K0.00%7K170.59%184K335.71%122K228.57%23K-86.21%4K-50.00%7K0.00%68K-17.65%28K-75.16%7K
Operating profit 37.90%-626K3.99%-771K-18.33%-4.03M-10.37%-1.14M-21.26%-1.08M-34.40%-1.01M-13.26%-803K0.00%-3.4M20.19%-1.03M-14.23%-889K
Net non-operating interest income expense -128.32%-258K-131.63%-227K1.60%-431K31.84%-122K-11.24%-99K-130.61%-113K-164.86%-98K0.00%-438K47.81%-179K25.79%-89K
Non-operating interest income 0.00%3K0.00%3K-45.83%13K103.75%3K0.00%3K-96.67%3K-96.88%3K0.00%24K-35.59%-80K-94.66%3K
Non-operating interest expense 125.00%261K127.72%230K-3.90%444K26.26%125K10.87%102K-16.55%116K-24.06%101K0.00%462K-65.14%99K-47.75%92K
Other net income (expense) 101.29%52K052K0.00%-4.03M
Special income (charges) ----------0----------------0.00%-4.1M--------
-Write off ----------0----------------0.00%4.1M--------
Other non- operating income (expenses) ---------21.21%52K--0----------52K0.00%66K--------
Income before tax 21.14%-884K-17.55%-998K44.05%-4.41M75.96%-1.26M-20.35%-1.18M-40.30%-1.12M-13.81%-849K0.00%-7.88M8.70%-5.25M-6.25%-978K
Income tax 00000000.00%-621K-378.12%-1.88M1,258,100.00%1.26M
Net income 21.14%-884K-17.55%-998K39.26%-4.41M62.54%-1.26M47.36%-1.18M-40.30%-1.12M-13.81%-849K0.00%-7.26M37.11%-3.37M-142.95%-2.24M
Net income continuous Operations 21.14%-884K-17.55%-998K39.26%-4.41M62.54%-1.26M47.36%-1.18M-40.30%-1.12M-13.81%-849K0.00%-7.26M37.11%-3.37M-142.95%-2.24M
Minority interest income 126.32%5K81.25%-36K65.20%-71K-550.00%-26K77.61%-15K71.64%-19K-149.35%-192K0.00%-204K-105.13%-4K41.72%-67K
Net income attributable to the parent company 19.33%-889K-46.42%-962K38.51%-4.34M63.27%-1.24M46.43%-1.16M-50.55%-1.1M1.79%-657K0.00%-7.05M38.08%-3.36M-169.30%-2.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 19.33%-889K-46.42%-962K38.51%-4.34M63.27%-1.24M46.43%-1.16M-50.55%-1.1M1.79%-657K0.00%-7.05M38.08%-3.36M-169.30%-2.17M
Basic earnings per share 19.33%-0.0773-46.42%-0.083738.51%-0.377163.27%-0.107446.43%-0.1011-50.55%-0.09581.81%-0.05710.00%-0.613338.08%-0.2924-169.30%-0.1886
Diluted earnings per share 19.33%-0.0773-46.42%-0.083738.51%-0.377163.27%-0.107446.43%-0.1011-50.55%-0.09581.81%-0.05710.00%-0.613338.08%-0.2924-169.30%-0.1886
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Recent IPOs
Recent IPOs
Intraday-0.58%